Deregulation of S1P metabolism and signaling occurs in various diseases as for example Alzheimer's disease (AD) and S1P receptors have been discovered as the target of several recently developed drugs (Couttas et al., 2014; van Echten-Deckert et al., 2014). The gene discussed is MBTPS1; the disease is Alzheimer disease.